BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 34336851)

  • 1. To Better Generate Organoids, What Can We Learn From Teratomas?
    Li H; Gao L; Du J; Ma T; Ye Z; Li Z
    Front Cell Dev Biol; 2021; 9():700482. PubMed ID: 34336851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular organoids: a new model to study the testicular microenvironment in vitro?
    Alves-Lopes JP; Stukenborg JB
    Hum Reprod Update; 2018 Mar; 24(2):176-191. PubMed ID: 29281008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of brain organoids from mouse ESCs via teratoma formation.
    Lee WJ; Lee JE; Hong YJ; Yoon SH; Song H; Park C; Hong K; Choi Y; Do JT
    Stem Cell Res; 2020 Dec; 49():102100. PubMed ID: 33260068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system organoids for modeling neurodegenerative diseases.
    Hou PS; Kuo HC
    IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems.
    Silva-Pedrosa R; Salgado AJ; Ferreira PE
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
    Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
    Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancement of Organoid Technology in Regenerative Medicine.
    Arjmand B; Rabbani Z; Soveyzi F; Tayanloo-Beik A; Rezaei-Tavirani M; Biglar M; Adibi H; Larijani B
    Regen Eng Transl Med; 2023; 9(1):83-96. PubMed ID: 35968268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on Three Dimensional Organoid Studies for Stem Cell Therapy in Regenerative Medicine.
    Mulaudzi PE; Abrahamse H; Crous A
    Stem Cell Rev Rep; 2024 Feb; 20(2):509-523. PubMed ID: 38095787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organoids in Tissue Transplantation.
    Sağraç D; Şişli HB; Şenkal S; Hayal TB; Şahin F; Doğan A
    Adv Exp Med Biol; 2021; 1347():45-64. PubMed ID: 34164796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of human adult stem or progenitor cell organoids.
    Rookmaaker MB; Schutgens F; Verhaar MC; Clevers H
    Nat Rev Nephrol; 2015 Sep; 11(9):546-54. PubMed ID: 26215513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary human organoids models: Current progress and key milestones.
    Calà G; Sina B; De Coppi P; Giobbe GG; Gerli MFM
    Front Bioeng Biotechnol; 2023; 11():1058970. PubMed ID: 36959902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in development and application of human organoids.
    Shankaran A; Prasad K; Chaudhari S; Brand A; Satyamoorthy K
    3 Biotech; 2021 Jun; 11(6):257. PubMed ID: 33977021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoids: The current status and biomedical applications.
    Yang S; Hu H; Kung H; Zou R; Dai Y; Hu Y; Wang T; Lv T; Yu J; Li F
    MedComm (2020); 2023 Jun; 4(3):e274. PubMed ID: 37215622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future.
    Devarasetty M; Mazzocchi AR; Skardal A
    BioDrugs; 2018 Feb; 32(1):53-68. PubMed ID: 29383499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synopsis of prostate organoid methodologies, applications, and limitations.
    Gleave AM; Ci X; Lin D; Wang Y
    Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling neoplastic disease with spheroids and organoids.
    Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
    J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organoid Culture Development for Skeletal Systems.
    Qing J; Guo Q; Lv L; Zhang X; Liu Y; Heng BC; Li Z; Zhang P; Zhou Y
    Tissue Eng Part B Rev; 2023 Oct; 29(5):545-557. PubMed ID: 37183418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.